Home › Psoriatic Arthritis › Georgia
Pag-aaral pangklinika para sa Psoriatic Arthritis sa Georgia
7 pag-aaral para sa Psoriatic Arthritis ang naghahanap ng mga kalahok sa mga site sa Georgia.
Opisyal na teksto ng pag-aaral (English)
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Emory University, Atlanta
- Children's Center for Digestive Healthcare, Atlanta
Nagre-recruitPhase 3
Edad 3 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06663332A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Atlanta Research Center for Rheumatology, Marietta
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07321873A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Marietta Rheumatology Associates, Marietta
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06671483Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Gainesville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- North Georgia Rheumatology Group PC, Lawrenceville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06671496Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Emory Children's Center, Atlanta
- Georgia Regents University Medical Center, Augusta
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT02418442Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- Parris and Associates, Lilburn
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 9, 2025 · NCT05669833Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.